Herbal Medicines Revolutionize Diabetes Care at CSIR Startup Conclave

The CSIR Startup Conclave in Lucknow highlighted India's push to integrate traditional medicines with modern science for innovative healthcare solutions. Featuring herbal formulations like the anti-diabetes drug BGR-34, the event emphasized India's potential as a global leader in herbal medicine. Government and industry leaders urged further commercialization of herbal innovations.

The recent CSIR Startup Conclave in Lucknow showcased India's growing expertise in blending traditional herbal medicine with modern scientific approaches. Industry experts and government officials gathered to discuss the future of affordable, globally competitive healthcare solutions driven by herbal innovation.

A significant highlight of the event was BGR-34, an anti-diabetes drug developed using six key herbs. The drug, already recognized for regulating blood sugar, is now being promoted for its potential in diabetes reversal. This aligns with a global trend focusing on reversing rather than just controlling diabetes.

Key speakers, including Union Science and Technology Minister Dr. Jitendra Singh, emphasized India's readiness to lead the herbal medicine sector globally. Singh and other officials encouraged startups to harness government-developed technologies to meet the rising international demand for natural remedies.

(With inputs from agencies.)